Source: MarketScreener

AavantiBio: AavantiBio to Present at the 40th Annual J.P. Morgan Healthcare Conference

(marketscreener.com) AavantiBio, a gene therapy company focused on transforming the lives of patients with rare genetic diseases, today announced that Bo Cumbo, President and Chief Executive Officer, will present at the 40th Annual J.P. Morgan Healthcare Conference. The live presentation and Q&A session, which will occur virtually, will take place on January 12,...https://www.marketscreener.com/news/latest/AavantiBio-to-Present-at-the-40th-Annual-J-P-Morgan-Healthcare-Conference--37460819/?utm_medium=RSS&utm_content=20220104

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Bo Cumbo's photo - President & CEO of AavantiBio

President & CEO

Bo Cumbo

CEO Approval Rating

89/100

Read more